BAM
IPCI

Belpointe Asset Management’s Intellipharmaceuticals International Inc. IPCI Stock Holding History

Belpointe Asset Management’s Portfolio IPCI Stock Details IPCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-3,079
Closed -$17K – 407
2018
Q1 		$17K Sell
3,079
-105
-3% -$759 0.01% 346
2017
Q4 		$25K Buy
+3,184
New +$28.9K 0.01% 455

Other funds holding IPCI

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
ATC
Argent Trust Co Nashville, Tennessee $3.46B AUM 30.37% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
AG
Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
VAM
Verity Asset Management Durham, North Carolina $264M AUM 28.52% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Belpointe Asset Management's IPCI Position: Q2 2018 in Review

Belpointe Asset Management sold out of Intellipharmaceuticals International Inc. (IPCI) in Q2 2018, closing a stake of 3,079 shares — an estimated $17K sold.

Belpointe Asset Management first reported a position in IPCI in Q4 2017 and held it in 2 quarters. The position peaked at $25K in Q4 2017. 24 funds tracked by Wall St. Rank hold IPCI as of Q2 2018.

  • Belpointe Asset Management reported no remaining Intellipharmaceuticals International Inc. position as of Q2 2018 after selling out during the quarter.
  • Belpointe Asset Management sold 3,079 Intellipharmaceuticals International Inc. shares in Q2 2018, an estimated $17K.
  • Belpointe Asset Management first reported a position in Intellipharmaceuticals International Inc. in Q4 2017 and held it in 2 quarters.
  • Belpointe Asset Management's Intellipharmaceuticals International Inc. position peaked at $25K in Q4 2017.
  • 24 funds tracked by Wall St. Rank held Intellipharmaceuticals International Inc. as of Q2 2018.

Based on Belpointe Asset Management's 13F filing for Q2 2018, filed 6 Aug 2018.